The effects of beta-adrenergic blockade produced by either oxprenolol or practolol in dogs anaesthetized with nitrous oxide and halothane were studied. The main changes were a fall in cardiac output, heart rate and stroke work index, and an increase in central venous pressure. These changes were more marked with practolol than with oxprenolol but this difference was probably due to a higher degree of beta-adrenergic stimulation during the control period in the dogs receiving practolol. The changes seen could, in the main, be attributed solely to beta-blockade. The possibility that the drugs are also direct myocardial depressants could not be ruled out as in some dogs showing no evidence of beta-stimulation in the control period negative inotropic effects were produced by both drugs. 15 15 15 15 15 15 3
Beta-adrenergic blockade under general anaesthesia has been advocated for a variety of purposes, but mainly to prevent or arrest cardiac arrhythmias The local anaesthetic or quinidinelike action of early agents, e.g. dl-propanolol, is well recognized, and is likely to produce myocardial depression (Epstein and Braunwald, 1966, 1967) , whereas it has been suggested that more recently developed agents, e.g. oxprenolol (Ciba 39089-Ba, Trasicor) and practolol (ICI 50172, Eraldin) , have less marked myocardial depressant effects (Kelly, 1968; Johnstone, 1969; Nayler and Lowe, 1968) .
While many studies of these drugs have been carried out in anaesthetized animals, the anaesthesia used, e.g. chloralose or pentobarbitone, has borne little relation to that used in clinical practice. It was, therefore, considered to be of interest to study the effects of beta-blockade in dogs with normal cardiac contractility during anaesthesia by more conventional agents. We chose nitrous oxide/oxygen/halothane following induction with sodium thiopentone. The beta-blocking agents investigated were oxprenolol and practolol.
METHOD
Healthy adult mongrel dogs, with body weights ranging from 10.75 kg to 16.75 kg, were used (table I) . Following approximately 4 hours starvation, anaesthesia was induced with sodium 1.5 1.5 1.5 1.5 1.5 1.5 1.0 0.3 thiopentone 250 mg (2.5 per cent solution) given intravenously over 30 sec. Intubation (which in the dog is easily performed without the aid of a muscle relaxant) was carried out and anaesthesia maintained with nitrous oxide (4 l./min), oxygen (2 l./min) and halothane 1 per cent (Fluotec vaporizer) using a Magill circuit. Respiration was spontaneous throughout, except that some dogs required brief respiratory assistance immediately following intubation. The electrocardiogram was recorded continuously and the pulse rate obtained from an electronic tachometer (Sanborn). Temperature was recorded from a rectal probe and maintained at 37°C (±1.5°C) by means of a heat source beneath the operating table. The right external jugular vein and right and left common carotid arteries were catheterized for measurement of central venous, aortic and left ventricular pressures respectively. Drugs were administered through an inferior vena caval catheter inserted through the right femoral vein. Pressures were recorded continuously from Sanborn 267BC pressure transducers calibrated against a mercury manometer.
Cardiac output was measured by the dyedilution technique using indocyanine green injected through the central venous catheter. Dye curves were obtained with a Waters 302 cuvette and densitometer and recorded on a 20 cm chart recorder (Servoscribe); curve areas were measured by the method of Williams, O'Donovan and Wood (1966) , which has been shown to correlate well with the method of Stewart and Hamilton (George et al., 1970) . Blood from the test animal and known amounts of dye were used for calibration purposes.
Left ventricular stroke work index (gm-m/kg) was calculated as follows: LVSWI = CO (l./min) x (MAP -CVP) (mm Hg) x 13.6
Heart rate/min x Body weight (kg)
Experimental protocol. Following insertion of the catheters, and allowing reasonable time (45-60 minutes after induction) for stabilization, control readings of each parameter were recorded at intervals of 150 sec for a total of 10 minutes. The test drug was then injected intravenously over a period of 90 sec and serial readings again taken at 150-sec intervals for 10 minutes after commencing injection of the drug. Two further observations were made at 10-minute intervals.
Six dogs received practolol 15 mg and six dogs received oxprenolol 1.5 mg. In addition, two dogs received oxprenolol 1.0 and 0.3 mg respectively, and a further animal was given practolol in a dose of 3 mg (table I) . These three animals were observed for a period of 1 hour prior to injection of the drug and, together with a further dog (given no beta-blocking agent and observed for 4 hours), gave evidence that dogs anaesthetized in the way described provided a stable haemodynamic preparation.
Horizontal and vertical means were taken for each parameter and the results plotted ( fig. 1 ), in terms of both absolute values and percentage changes. The control values for each parameter in one treatment group were compared statistically with those of the other using the Mann-Whitney U-test. Values for each parameter, before and after the drug, were compared using Student's Mest. Means of haemodynamic parameters before and after administration of either oxprenolol or practolol during nitrous oxide/halothane anaesthesia. The absolute values are shown on the left and the percentage changes on the right.
RESULTS
The results are shown in tables II-VII and in figures 1 and 2. Cardiac output (table II) . With both drugs there was a reduction in cardiac output, more marked in the case of practolol. The mean maximum reduction in the case of oxprenolol was 21 per cent (4-48 per cent) (0.10>P>0.05) whereas with practolol the reduction was 45 per cent (11-71 per cent) (P<0.005). A f-test performed on the pooled data from both series, looking at maximum percentage changes from control in cardiac output, showed a significantly greater percentage decrease following practolol (P<0.05).
PRACTOLOL 15mo
OXPRENOLOL V5mg The fall in cardiac output was generally rapid and remained throughout the 30 minutes of the observation period. The initial level of cardiac output did not appear to influence the degree of fall, but dogs with high initial heart rates had the greatest reduction in output. Those dogs receiving the smaller doses of each drug also showed falls of the same order as those receiving the higher dose.
Heart rate (table HI) . There was a considerable slowing of the heart rate, especially in the case of practolol. Using either a differential f-test or a (-test for a single sample, this was significant (P<0.05) for practolol, but not for oxprenolol.
The differences between the two groups were not significant.
The difference between the two drugs in this situation may be due to the high initial heart rates seen in some of the dogs receiving practolol.
Stroke volume (table IV) . While most dogs had a fall in stroke volume following beta-blockade, this was not always the case. The mean fall was greater with practolol. Differences, before and after treatment, and between the drugs, were not significant. The main fall in cardiac output was, therefore, due to the bradycardia produced by these drugs, but, in most cases, there was also a reduced stroke volume.
Mean arterial pressure (table V) . There was a fall in mean arterial pressure with both drugs, again more marked in the case of practolol which produced a rapid fall compared to a rather slower fall in the case of oxprenolol. Whether maximum percentage or overall mean changes are considered, this fall was significant after practolol (0.02>P>0.01) but not after oxprenolol. The mean value of mean arterial pressure was lower after oxprenolol but this is probably due to the inclusion of dog 2 who was hypotensive throughout the experiment.
Central venous pressure (table VI) . There was a rise in c.v.p., especially in the case of practolol. With oxprenolol the rise was minimal, whereas with practolol it varied from small to moderate.
In our experience of c.v.p. changes encountered in other experiments, and considering these changes qualitatively, there was little doubt that the rise following practolol was physiologically significant. However, this could not be confirmed by statistical analysis (0.1>P>0.05) and the difference between the drugs was significant only at the 10 per cent level. It was considered inappropriate to compare percentage changes as these are influenced greatly by low control levels.
Stroke work index (table VII) . This parameter, which relates stroke volume to the work of the left ventricle against pressure, gives an indication of myocardial contractility irrespective of heart rate.
Following beta-blockade, there was usually a fall in SWI, although occasionally there was a rise. The mean maximal fall in the case of oxprenolol was 7 per cent compared with 35 per cent after practolol, but this difference was not 
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No. significant. A differential f-test performed on individual series, looking at maximum changes from control, showed that the reduction following practolol was significant (0.05>P>0.025).
In dogs 7, 8 and 15, which were observed over a period of 1 hour before administering the betablocking drug, there was no variation in their haemodynamic state during this time. The additional dog observed for 4 hours also showed no marked or sustained variation.
DISCUSSION
The main object of this investigation was to attempt to reproduce in dogs anaesmesia similar to that used in man and to test the effects of beta-blocking drugs on this state. The drugs chosen were both of the newer type of betablocking agent, said to have a selective action on the beta-receptors in the heart and it is claimed that they have minimal depressant effects on myocardial contractility.
The use of nitrous oxide/halothane anaesthesia for experimental work in dogs was found to be easy, and we would like to see it replace, to some extent, agents such as chloralose and pentobarbitone in experimental pharmacology, especially where the drugs investigated have a possible use in anaesthesia. From die haemodynamic point of view, dogs anaesthetized with nitrous oxide/ halodiane remain in a stable state and are, therefore, suitable for die investigation of drugs likely to affect the circulation.
The two series of dogs used in these experiments are not truly comparable because of the differences in the control states. Some of the dogs who received practolol had raised cardiac outputs and heart rates and it could be assumed that there was a degree of catecholamine stimulation present before administration of the beta-blocking agent.
One animal (dog 9) is worthy of special mention. The very rapid rate seen in diis dog was due to almost continuous supraventricular and ventricular extrasystoles. Myocardial contraction resulting from the premature beats was so inefficient that the aortic valve did not open widi all ventricular contractions, as evidenced by the ventricular and aortic pressure recordings. The gross arrhythmia seen in this dog was rapidly reversed by practolol. It might have been expected that the cardiac output would not seriously suffer in this case, or might even improve, but, in fact, there was a marked and potentially serious fall. Ten minutes after administration of the drug die arrhythmia recurred; cardiac output fell further, to such an extent that the dye curves could not be reliably interpreted. This situation remained substantially unchanged during subsequent observation and the animal was sacrificed 30 minutes after injection.
It must be remembered diat potent anaesthetic agents may have a dual action upon the heart; direct depression and stimulation due to catecholamine release, die latter possibly being augmented by hypercarbia arising from respiratory depression. Thus a beta-blocking drug may counteract die catecholamine effect leaving the direct depression of die myocardium unopposed. Certain agents, e.g. edier and cyclopropane, are said to release catecholamines (hence the apparent lack of circulatory depression even under deep anaesdiesia widi diese agents (Brewster, Isaacs and Wain0-Anderson, 1953) ). Halodiane, on die odier hand, is not diought to cause catecholamine release, but diis conclusion must await further confirmation.
It is of interest diat bodi series of dogs reached very similar levels of cardiac output and heart rate after beta-blockade had been achieved, and it could be said diat die control differences were, dierefore, in terms of catecholamine stimulation. Thus die major falls in cardiac output occurred in dogs widi high heart rates. However, it must be pointed out diat often falls in cardiac output were seen widi little change in heart rate (dogs 1, 5 and 13) and negative inotropism was seen widi bodi drugs in dogs with little evidence of beta-stimulation during the control period.
When consideration is taken of die rise in central venous pressure and fall in stroke work index, it is obvious diat diere is a loss of myocardial contractility. This negative inotropism could be die result of removing die catecholamine stimulus, aldiough the possibility diat the drugs have a direct effect upon die myocardium cannot be ruled out. Nayler and Lowe (1968) , studying left ventricular work preparations in dogs and isolated papillary muscle, considered diat practolol provided effective beta-blockade widiout causing myocardial depression. In these studies, however, halothane was not used. Johnstone (1969) concluded, on the basis of clinical studies employing venous occlusion plethysmography, that in patients with beta-adrenergic stimulation practolol causes no direct myocardial depression. This study did not, however, include measurement of central blood flow.
The results presented here are similar to those of Norman and Atkinson (1970) who found evidence of marked loss of myocardial contractility in anaesthetized dogs with increased betaadrenergic activity secondary to hypercarbia.
There is probably little difference in the effect produced by either practolol or oxprenolol, as evidenced by the similarity of the parameters measured following administration. Beta-blockade is not an easily denned state and there is the problem of judging the dosage of the drugs to be equipotent. In this we were guided by the manufacturers' advice and the dosage used by previous workers, which was very high on a weight-toweight basis compared with that recommended in man. The few animals in this series given much lower dosage showed changes similar to those occurring with high dosage. It may be assumed, therefore, that beta-blockade was fully effective in the main series.
SOMMAIRE
Les effets de bloquage bsta-adre'nergique produit par oxprenolol ou practolol chez des chiens anesthesies au protoxyde d'azote et halothane, furent etudies. Les principales modifications furent une reduction du dibit cardiaque, de la frequence cardiaque et de l'index pulsation-travail, ainsi qu'une augmentation de la pression veineuse centrale. Ces alterations furent plus marquees avec practolol qu'avec oxprenolol mail cette difference est due probablement au plus fort degre' de stimulation beta-adrenergique durant la periode de controle chez les chiens, recevant practoloL Les modifications observers purent en general £tre attributes uniquement au bloquage beta. La possibiliti que les medicaments detriment aussi directement le myocarde n'a pas pu fitre exclue, car chez certains chiens sans signes de stimulation beta au cours de la periode de controle, on observa avec les deux medicaments des effets inotropes negatifs.
HAMODYNAMISCHE WIRKUNG VON OXPRENOLOL UND PRACTOLOL BEI HUNDEN IN HALOTHAN-NARKOSE
ZUSAMMENFASSXJNG
Es wurden die Wirkungen einer durch Oxprenolol oder PTactolol hervorgerufenen /3-adrenergischen Blockade bei Hunden, die mit Lachgas und Halothan anaesthesiert worden waren, untersucht. Die hauptsachlichen Veranderungen bestanden in einem Absinken der Herzleistung, der Herzfrequenz und des Schlagvolumenindex, sowie in erhohtem zentralen Venendruck. Diese Veranderungen waren bei Practolol ausgepragter als bei Oxprenolol, was aber vennutlich auf cine stSrkere /3-edrenergische Stimuherung wahrend der Kontrollzeit bei den mit Practolol behandelten Hunden zuruckzuffihren war. Im wesentlichen konnten die beobachteten Veranderungen allein der Wirkung der ^-Blockade zugeschrieben werden. Die Moglichkeit, da6 die Medikamente auch eine direkte Myokarddepression hervorrufen konnen, konnte nicht ausgeschlossen werden, da bei einigen Hunden, welche wahrend der Kontrollzeit keine Zeichen einer /3-Stimulierung zeigten, negativ inotrope Wirkungen durch beide Pharmaka hervorgerufen wurden.
